Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Comparable GH release to GHRP-6 without the cortisol, prolactin, or appetite effects
This usually settles as your body adjusts
Market Segmentation Short-acting Long-acting Dual-action Type 2 Diabetes Obesity Cardiovascular Diseases Subcutaneous Injection Oral Inhalation Hospital Pharmacies Retail Pharmacies Online Pharmacies Report Scope FAQs The GLP-1 Drug Market was valued at 10.77 USD Billion in 2024
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not a pure GLP-1 agent
US$ 21.68
US$ 20.48
US$ 29.75
US$ 24.38
